05.18.26 -- Selecting a Sustainable CDMO Partner for your Small Molecule Program

Sustainability has evolved from an optional add-on into an essential optimization tool for drug development. By integrating greener materials and process intensification, developers achieve lower costs and faster market entry. While balancing short-term costs, sustainability ultimately drives long-term efficiency and regulatory compliance.

Sustainability has become a critical focus in pharmaceutical manufacturing, especially in the production of Active Pharmaceutical Ingredients (APIs), which contribute significantly to global emissions. As the industry faces increasing scrutiny and regulatory demands, the need for more sustainable practices has never been more urgent.

Sustainable pharmaceutical manufacturing starts at the chemistry bench. By redesigning synthetic routes with green chemistry principles, manufacturers can lower emissions, minimize solvent use, and reduce waste without sacrificing product quality or throughput. See how smarter synthesis and digital tools enable sustainable API manufacturing.

Ensure the success of your program with a committed CDMO that meets your needs and navigates complexity with you. Choosing a CDMO that integrates sustainability by design can enhance efficiency while maintaining safety standards. With 35+ years of experience, MilliporeSigma is the partner to support you every step of the way.